Lycium barbarum (Goji)
TRADITIONAL ASIAN · Evidence Monograph
Lycium barbarum (Goji) is an evidence-graded traditional asian monograph evaluated across 30 peer-reviewed PubMed studies (1 meta-analyses, 3 systematic reviews, and 4 randomized controlled trials, encompassing n = 1,749 cumulative participants). Current clinical evidence is rated GRADE High (4.0 / 4.0) for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support.
Evidence Supports Supplementation When:
- 01 Individuals seeking evidence-backed support for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support (supported by 30 indexed PubMed studies, GRADE High).
- 02 Adults matching clinical trial dosing protocols (400 mg · 28 g · 6 mg) over a structured 90 days evaluation window.
- 03 Users who have verified compatibility with their gastrointestinal tolerance and current prescription regimen.
Avoid or Consult Physician When:
- 01 Patients on narrow-therapeutic-index prescription medications (anticoagulants, immunosuppressants, thyroid hormones) without medical supervision.
- 02 Pregnant or lactating women, pediatric individuals, or patients with severe hepatic or renal impairment unless explicitly prescribed by a physician.
- 03 Anyone already taking overlapping multivitamin or multi-ingredient complexes that would push daily intake above upper tolerability limits.